Kaiser Permanente
Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Patients reported positive outcomes with use of an HIV prevention medication dosed only as needed, instead of the more common daily dosing, Kaiser Permanente researchers reported.
A JAMA study, using data on patients hospitalized in March from all 21 Kaiser Permanente Northern California hospitals, is one of the first U.S. studies to look at overall hospitalization admissions of COVID-19 patients.
A Kaiser Permanente study of women who were given inactivated influenza vaccine while pregnant found no indication of developmental problems for their babies at 6 months old.
Women who had an untreated infection during pregnancy were more likely to have a child who later went on to be obese than pregnant women who never had an infection, new research from Kaiser Permanente finds.
Black patients being treated for hepatitis C can take 8 weeks of certain direct-acting antiviral drugs rather than the previous recommendation of 12 weeks, updated guidelines say.
Kaiser Permanente researchers have developed a new analytical tool that identifies people at risk of contracting HIV so they may be referred for preventive medication.
A single, 45-minute “motivational interview” with two 20-minute follow-up phone calls may help people with HIV who report unhealthy drinking reduce their alcohol intake, say researchers at UC San Francisco and Kaiser Permanente.
Division of Research investigators participated in a multi-institution collaborative analysis, which supported the safety of current transfusion practice within Kaiser Permanente’s network of community hospitals.
Children who were up to date on their pertussis vaccine schedule were far less likely to develop the disease than those unvaccinated. The risk of vaccinated children becoming ill increased with time since vaccination, suggesting waning effectiveness.
Direct-acting antiviral agents used to treat patients with the hepatitis C virus are not associated with higher rates of adverse liver, kidney, and cardiovascular events, according to research published in JAMA Network Open and supported by data from Kaiser Permanente Northern California.
